Sarepta Therapeutics enters into an agreement to sell to Gilead its FDA Rare Pediatric Disease Priority Review Voucher for $125 million.
The U.S. District Court for the Western District of Louisiana enters a consent decree against dietary supplement maker Pick and Pay Inc./Cili Mineral ...
FDA Review posts product approval summaries for the week ending 2/17/2017.
FDA Review posts the latest Federal Register notices posted the week ending 2/17/2017.
Federal Register Notice: FDA issues an order to permanently debar Raymond Sean Brown from providing services in any capacity to a person that has an a...
The Government Accountability Office criticizes FDA staff vacancies at foreign agency posts and continued struggles with drug shortages as part of its...
Federal Register Notice: FDA issues an order debarring Karis Copper Delong for a period of 12 years from providing services in any capacity to a perso...
FDA approves a Perrigo ANDA for hydrocodone bitartrate and homatropine methylbromide oral solution (syrup), 5mg/1.5mg per 5mL, indicated for cough.